KYNB Insider Transactions — Page 10
918 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 901–918; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Neff Thomas B | Chief Executive Officer | 2015-08-06 | Sale | 500.0 | $24.13 |
| Neff Thomas B | Chief Executive Officer | 2015-08-06 | Sale | 3,700.0 | $23.7 |
| Neff Thomas B | Chief Executive Officer | 2015-08-06 | Sale | 9,300.0 | $22.4 |
| Neff Thomas B | Chief Executive Officer | 2015-08-05 | Sale | 13,500.0 | $23.82 |
| VALONE FRANK H MD | Chief Medical Officer | 2015-08-03 | Sale | 10,000.0 | $23.37 |
| Neff Thomas B | Chief Executive Officer | 2015-07-23 | Sale | 13,500.0 | $24.8 |
| Neff Thomas B | Chief Executive Officer | 2015-07-22 | Sale | 13,500.0 | $24.62 |
| VALONE FRANK H MD | Chief Medical Officer | 2015-07-20 | Sale | 1,000.0 | $23.7 |
| Cotroneo Pat | VP, Finance and CFO | 2015-07-20 | Sale | 2,500.0 | $24.0 |
| Cotroneo Pat | VP, Finance and CFO | 2015-07-17 | Sale | 5,381.0 | $23.23 |
| Neff Thomas B | Chief Executive Officer | 2015-07-09 | Sale | 13,500.0 | $22.13 |
| Neff Thomas B | Chief Executive Officer | 2015-07-08 | Sale | 13,500.0 | $22.08 |
| Yu K Peony | VP, Clinical Development | 2015-07-06 | Sale | 2,600.0 | $22.83 |
| Yu K Peony | VP, Clinical Development | 2015-07-06 | Sale | 2,781.0 | $22.56 |
| Neff Thomas B | Chief Executive Officer | 2015-06-25 | Sale | 13,500.0 | $23.52 |
| Neff Thomas B | Chief Executive Officer | 2015-06-24 | Sale | 500.0 | $23.93 |
| Neff Thomas B | Chief Executive Officer | 2015-06-24 | Sale | 11,031.0 | $23.6 |
| Neff Thomas B | Chief Executive Officer | 2015-06-24 | Sale | 1,969.0 | $23.62 |